Faculty

Jeet Mohite, M.D., M.P.H.

Clinical Studies

Partnership Program In Precision Psychiatry Biobank (P3 Biobank) Mankato, Minn., Rochester, Minn., Austin, Minn.
The purpose of this study is to create a a large database and bio-repository of clinical information and blood samples from participants with BD type- I (BD-I), type- II (BD-II) and schizoaffective disorder, bipolar type (SCZ-BD) and extending an invitation for some of our previous patients who participated in the Mayo Clinic Bipolar Biobank from 2009 to 2018 and MoStGEN Biobank from 2021 to 2025 to have them return for a second new blood draw for this new protocol.

Partnership Program In Precision Psychiatry Biobank (P3 Biobank) Scottsdale/Phoenix, Ariz., Eau Claire, Wis.
The purpose of this study is to create a a large database and bio-repository of clinical information and blood samples from participants with BD type- I (BD-I), type- II (BD-II) and schizoaffective disorder, bipolar type (SCZ-BD) and extending an invitation for some of our previous patients who participated in the Mayo Clinic Bipolar Biobank from 2009 to 2018 and MoStGEN Biobank from 2021 to 2025 to have them return for a second new blood draw for this new protocol.

Mood Stabilizer Pharmacogenomics Biobank (MoStGEN) Rochester, Minn., Mankato, Minn., Austin, Minn., Scottsdale/Phoenix, Ariz.
The purpose of this study is to create a larger database and bio-repository to examine pharmacogenomics in patients with BD type I and type II treated with mood stabilizing anticonvulsants, atypical antipsychotics and antidepressant medications.